Literature DB >> 22730389

Minimal effect of collateral flow on coronary microvascular resistance in the presence of intermediate and noncritical coronary stenoses.

Bart-Jan Verhoeff1, Tim P van de Hoef, Jos A E Spaan, Jan J Piek, Maria Siebes.   

Abstract

Depending on stenosis severity, collateral flow can be a confounding factor in the determination of coronary hyperemic microvascular resistance (HMR). Under certain assumptions, the calculation of HMR can be corrected for collateral flow by incorporating the wedge pressure (P(w)) in the calculation. However, although P(w) > 25 mmHg is indicative of collateral flow, P(w) does in part also reflect myocardial wall stress neglected in the assumptions. Therefore, the aim of this study was to establish whether adjusting HMR by P(w) is pertinent for a diagnostically relevant range of stenosis severities as expressed by fractional flow reserve (FFR). Accordingly, intracoronary pressure and Doppler flow velocity were measured a total of 95 times in 29 patients distal to a coronary stenosis before and after stepwise percutaneous coronary intervention. HMR was calculated without (HMR) and with P(w)-based adjustment for collateral flow (HMR(C)). FFR ranged from 0.3 to 1. HMR varied between 1 and 5 and HMR(C) between 0.5 and 4.2 mmHg·cm(-1)·s. HMR was about 37% higher than HMR(C) for stenoses with FFR < 0.6, but for FFR > 0.8, the relative difference was reduced to 4.4 ± 3.4%. In the diagnostically relevant range of FFR between 0.6 and 0.8, this difference was 16.5 ± 10.4%. In conclusion, P(w)-based adjustment likely overestimates the effect of potential collateral flow and is not needed for the assessment of coronary HMR in the presence of a flow-limiting stenosis characterized by FFR between 0.6 and 0.8 or for nonsignificant lesions.

Entities:  

Mesh:

Year:  2012        PMID: 22730389     DOI: 10.1152/ajpheart.00003.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

Review 1.  Coronary microvascular dysfunction: mechanisms and functional assessment.

Authors:  Paolo G Camici; Giulia d'Amati; Ornella Rimoldi
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 2.  Myocardial perfusion distribution and coronary arterial pressure and flow signals: clinical relevance in relation to multiscale modeling, a review.

Authors:  Froukje Nolte; Eoin R Hyde; Cristina Rolandi; Jack Lee; Pepijn van Horssen; Kal Asrress; Jeroen P H M van den Wijngaard; Andrew N Cookson; Tim van de Hoef; Radomir Chabiniok; Reza Razavi; Christian Michler; Gilion L T F Hautvast; Jan J Piek; Marcel Breeuwer; Maria Siebes; Eike Nagel; Nic P Smith; Jos A E Spaan
Journal:  Med Biol Eng Comput       Date:  2013-07-27       Impact factor: 2.602

3.  Invasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease.

Authors:  Guus A de Waard; Sukhjinder S Nijjer; Martijn A van Lavieren; Nina W van der Hoeven; Ricardo Petraco; Tim P van de Hoef; Mauro Echavarría-Pinto; Sayan Sen; Peter M van de Ven; Paul Knaapen; Javier Escaned; Jan J Piek; Justin E Davies; Niels van Royen
Journal:  J Am Heart Assoc       Date:  2016-12-22       Impact factor: 5.501

Review 4.  Definition and epidemiology of coronary microvascular disease.

Authors:  Conor Bradley; Colin Berry
Journal:  J Nucl Cardiol       Date:  2022-05-09       Impact factor: 3.872

5.  Three-Dimensional Angiographic Characteristics versus Functional Stenosis Severity in Fractional and Coronary Flow Reserve Discordance: A DEFINE FLOW Sub Study.

Authors:  Valerie Stegehuis; Jelmer Westra; Coen Boerhout; Martin Sejr-Hansen; Ashkan Eftekhari; Hernan Mejía-Renteria; Maribel Cambero-Madera; Niels Van Royen; Hitoshi Matsuo; Masafumi Nakayama; Maria Siebes; Evald Høj Christiansen; Tim Van de Hoef; Jan Piek
Journal:  Diagnostics (Basel)       Date:  2022-07-21

6.  Comparing the effect of clopidogrel versus ticagrelor on coronary microvascular dysfunction in acute coronary syndrome patients (TIME trial): study protocol for a randomized controlled trial.

Authors:  Sang-Don Park; Yong-Soo Baek; Seong-Ill Woo; Soo-Han Kim; Sung-Hee Shin; Dae-Hyeok Kim; Jun Kwan; Keum-Soo Park
Journal:  Trials       Date:  2014-05-01       Impact factor: 2.279

7.  Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian-Dutch-English (IDEAL) collaborators.

Authors:  Sukhjinder S Nijjer; Guus A de Waard; Sayan Sen; Tim P van de Hoef; Ricardo Petraco; Mauro Echavarría-Pinto; Martijn A van Lavieren; Martijn Meuwissen; Ibrahim Danad; Paul Knaapen; Javier Escaned; Jan J Piek; Justin E Davies; Niels van Royen
Journal:  Eur Heart J       Date:  2015-11-26       Impact factor: 29.983

Review 8.  Coronary Microcirculation in Aortic Stenosis: Pathophysiology, Invasive Assessment, and Future Directions.

Authors:  Jo M Zelis; Pim A L Tonino; Nico H J Pijls; Bernard De Bruyne; Richard L Kirkeeide; K Lance Gould; Nils P Johnson
Journal:  J Interv Cardiol       Date:  2020-07-22       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.